Main Article Content

Natalya Vladimirovna Artymuk
Olga Olegovna Chernova
Nadezhda Vladimirovna Averina

Abstract

The aim of the research – to evaluate the diagnostic utility of various endometrial sampling methods based on an analysis of contemporary publications (covering the period 2017-2026).
Materials and Methods. A search was conducted using the PubMed and E-library databases. Key words included: diagnosis of endometrial hyperplasia and endometrial biopsy. The search scope spanned 10 years (2017-2026).
Results: The search yielded 2,126 sources (1,400 from PubMed and 726 from E-library). The following were excluded from the analysis: publications for which the full text was unavailable (n = 4); literature reviews or opinion pieces lacking original data (n = 2); publications deemed irrelevant based on their titles (n = 1,730); duplicate reports (n = 300); and studies that did not compare different sampling methods (n = 83). Seven publications met the inclusion criteria. Diagnosing endometrial hyperplasia via Pipelle biopsy or manual vacuum aspiration (MVA) serves as a reliable, less invasive alternative to traditional diagnostic curettage in patients with diffuse endometrial processes. These procedures can be performed on an outpatient basis without cervical dilation or anesthesia. Consequently, women with endometrial hyperplasia can be evaluated in an outpatient setting, avoiding the need for hospitalization, cervical dilation, or anesthesia. However, if a focal lesion is suspected, or if a "blind" biopsy yields non-diagnostic results, office hysteroscopy with targeted biopsy is required.
Conclusions.The morphological verification of endometrial hyperplasia necessitates the optimization of diagnostic approaches. The high accuracy, safety, and accessibility of MVA (manual vacuum aspiration) and Pipelle biopsy make them an effective alternative to traditional curettage. However, determining their applicability in cases of focal pathology and postmenopausal atrophy requires further prospective studies.

Keywords

diagnosis of endometrial hyperplasia, Pipelle biopsy, MVA

Author Biographies

Natalya Vladimirovna Artymuk,

doctor of medical sciences, professor, head of the department of obstetrics and gynecology named after G.A. Ushakova

Olga Olegovna Chernova,

obstetrician-gynecologist, gynecological department N 2

Nadezhda Vladimirovna Averina,

Assistant of the Department of Obstetrics and Gynecology named after G.A. Ushakova

Article Details

Information about financing and conflict of interests

The study had no sponsorship.
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.

How to Cite

Artymuk, N. V., Chernova, O. O., & Averina, N. V. (2026). DIAGNOSTIC VALUE OF VARIOUS ENDOMETRIAL SAMPLING METHODS FOR ENDOMETRIAL HYPERPLASIA. Mother and Baby in Kuzbass, 4. https://mednauki.ru/index.php/MD/article/view/1573

References

1. Contreras NA, Sabadell J, Verdaguer P, Julià C, Fernández-Montolí ME. Fertility-preserving approaches in patients with atypical endometrial hyperplasia and endometrial cancer: current evidence and future perspectives. Int J Mol Sci. 2022; 23(5): 2531. doi: 10.3390/ijms23052531

2. Restaino S, Paglietti C, Paparcura F, Bogani G, Capozzi VA, Catena U, et al. Management of Patients Diagnosed with Endometrial Hyperplasia: Comparison of Guidelines. Cancers (Basel). 2026; 18(13): 2048. doi: 10.3390/cancers18132048

3. Singh G, Cue L, Puckett Y. Endometrial Hyperplasia. 2024 Apr 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK560693/

4. Giannella L, Grelloni C, Bernardi M, Cicoli C, Lavezzo F, Sartini G, et al. Atypical Endometrial Hyperplasia and Concurrent Cancer: A Comprehensive Overview on a Challenging Clinical Condition. Cancers (Basel). 2024; 16(5): 914. doi: 10.3390/cancers16050914

5. Artymuk NV, Kharenkova EL, Tachkova OA. Efficacy of indole carbinol in patients with simple endometrial hyperplasia without atypia in perimenopause. Obstetrics and Gynecology. 2020; (2): 154-159. Russian (Артымук Н.В., Харенкова Е.Л., Тачкова О.А. Эффективность индолкарбинола у пациенток с простой, без атипии, гиперплазией эндометрия в перименопаузе //Акушерство и Гинекология. 2020. № 2. С. 154-159.) doi: 10.18565/aig.2020.2.154-159

6. Galani A, Stavros S, Moustakli E, Potiris A, Zikopoulos A, Anagnostaki I, et al. Endometrial Hyperplasia: Current Insights into Epidemiology, Risk Factors, and Clinical Management. Cancers (Basel). 2025; 18(1): 148. doi: 10.3390/cancers18010148

7. Ye J, Mm XQ, Qi X. Fertility-preserving treatment for endometrial atypical hyperplasia and endometrial cancer: a systematic review and meta-analysis. BMC Womens Health. 2026; 26(1): 226. doi: 10.1186/s12905-026-04352-y

8. Nees LK, Heublein S, Steinmacher S, Juhasz-Böss I, Brucker S, Tempfer CB, Wallwiener M. Endometrial hyperplasia as a risk factor of endometrial cancer. Arch Gynecol Obstet. 2022; 306(2): 407-421. doi: 10.1007/s00404-021-06380-5

9. Sviridova NI, Tkachenko LV, Yakhontova MA, Gritsenko IA, Maximov SN, Puryaseva KA. Endometrial hyperplastic processes: modern approaches to diagnosis and treatment. Obstetrics, Gynecology and Reproduction. 2024; 18(1): 83-95. Russian (Свиридова Н.И., Ткаченко Л.В., Яхонтова М.А., Гриценко И.А., Максимов С.Н., Пурясева К.А. Гиперпластические процессы эндометрия: современные подходы к диагностике и лечению //Акушерство, гинекология и репродукция. 2024. Т. 18, № 1. С. 83-95.) doi: 10.17749/23137347/ob.gyn.rep.2023.464

10. Vitale SG, Riemma G, Carugno J, Chiofalo B, Vilos GA, Cianci S, et al. Hysteroscopy in the treatment of endometrial hyperplasia and cancer in reproductive-age women: new developments and current perspectives. Transl Cancer Res. 2020; 9(12): 7767-7777. doi: 10.21037/tcr-20-2092

11. Bryce C, Gazda R, Fuerst H. Endometrial Cancer: Rapid Evidence Review. Am Fam Physician. 2025; 111(6): 526-531.

12. Hansadah S, Balakrishnan D, Sethy M. A Comparative Analysis of the Pipelle Device and Conventional Dilatation and Curettage as Investigative Tools for Abnormal Uterine Bleeding: Assessing Sample Adequacy and Patient Perspectives: A Prospective Observational Cohort Study. J Midlife Health. 2025; 16(3): 278-284. doi: 10.4103/jmh.jmh_13_25

13. Damirov MM, Yurchenko OB, Titova GP, Borovkova NV, Ierusalimskiy AP. Modern approaches to the diagnosis of endometrial hyperplasia. Bulletin of the Medical Institute «REAVIZ» (rehabilitation, doctor and health). 2024; 14(6): 78-86. Russian (Дамиров М.М., Юрченко О.Б., Титова Г.П., Боровкова Н.В., Иерусалимский А.П. Современные подходы к диагностике гиперплазии эндометрия //Вестник Медицинского института «РЕАВИЗ»: Реабилитация, врач и здоровье. 2024. Т. 14, № 6. С. 78-86.) doi: 10.20340/vmi-rvz.2024.6.CLIN.5

14. Kuznetsova IV, Vedzizheva ER. Current approaches to diagnosing and preventing endometrial hyperplasia: A review. Gynecology. 2025; 27(1): 73-80. Russian (Кузнецова И.В., Ведзижева Э.Р. Современные подходы к диагностике и профилактике гиперплазии эндометрия //Гинекология. 2025. Т. 27, № 1. С. 73-80.) doi: 10.26442/20795696.2025.1.203179

15. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011; 155(8): 529-536. doi: 10.7326/0003-4819-155-8-201110180-00009

16. Di Spiezio Sardo A, Saccone G, Carugno J, Pacheco LA, Zizolfi B, Haimovich S, Clark TJ. Endometrial biopsy under direct hysteroscopic vision compared with blind sampling for the diagnosis of endometrial hyperplasia and cancer: systematic review and meta-analysis. Facts Views Vis Obgyn. 2022; 14(2): 103-110. doi: 10.52054/FVVO.14.2.023

17. Saito E, Matsumoto Y, Nitta S, Fujino S, Tsuruga T, Mori-Uchino M, et al. Manual vacuum aspiration (women's MVA) for endometrial biopsy in patients with suspected endometrial malignancies. J Obstet Gynaecol Res. 2022; 48(11): 2896-2902. doi: 10.1111/jog.15403

18. Ozturk F, Sagnic S, Firtina Tuncer S, Tuncer HA. Diagnostic efficiency of endometrial sampling methods and risk factors for endometrial cancer and premalignant lesions in premenopausal women. J Clin Med. 2025; 14(11): 3658. doi: 10.3390/jcm14113658

19. Narice BF, Delaney B, Dickson JM. Endometrial sampling in low-risk patients with abnormal uterine bleeding: a systematic review and meta-synthesis. BMC Fam Pract. 2018; 19: 135. doi: 10.1186/s12875-018-0817-3

20. Mishra S, Ratoria R, Parihar A, Singh S, Agrawal S, Chaudhary E, et al. Pipelle Endometrial Biopsy Versus Conventional Dilation and Curettage for the Diagnosis of Endometrial Pathology in Abnormal Uterine Bleeding. Cureus. 2025; 17(9): e91794. doi: 10.7759/cureus.91794

21. Behnamfar F, Arshad E. Diagnostic Values of Pipelle and Standard Curettage Compared to Hysterectomy Pathology in Postmenopausal Bleeding: A Comparative Study. Adv Biomed Res. 2020; 9: 58. doi: 10.4103/abr.abr_28_20

22. Gupta M, Gupta P, Yadav P. A Randomized Comparative Study to Compare Karman's Cannula and Pipelle Biopsy for Evaluation of Abnormal Uterine Bleeding. J Midlife Health. 2022; 13(1): 67-73. doi: 10.4103/jmh.jmh_292_20

23. Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia: ACOG Clinical Consensus N 5. Obstet Gynecol. 2023; 142(3): 735-744. doi: 10.1097/AOG.0000000000005297

24. Management of Endometrial Hyperplasia (Green-top Guideline N 67) Royal College of Obstetricians and Gynaecologists (RCOG), British Society for Gynaecological Endoscopy (BSGE). London: RCOG, 2016. 32 p. https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/management-of-endometrial-hyperplasia-green-top-guideline-no-67/

Downloads

Download data is not yet available.

Most read articles by the same author(s)